Why 2018 Could be Alnylam’s Best Year Yet

Some achievements are hard to top.

Some achievements are hard to top. Alnylam Pharmaceuticals (NASDAQ:ALNY), for example, saw its stock price soar 249% in 2017. That’s not an easy feat to pull off in one year, much less to do it again.

But will 2018 be Alnylam’s best year yet?

MORE ON THIS TOPIC